Atrial Fibrillation

Latest Headlines

ACC 2015
ACC 2015
More than 13,000 physicians and cardiovascular team members attended the ACC 2015 meeting in San Diego on March 14-16, 2015. In this issue of Cardiology Review, we focus on 6 important studies presented at ACC 2015: LEGACY, OSLER, PEGASUS, EMBRACE-STEMI, MATRIX, and CoreValve.
Heart Failure Drug Approved, and Other Cardiology News
The recent FDA approvals of ivabradine and the WATCHMAN Left Atrial Appendage Closure Device, study results on EHRs and quality of medical care, and more are covered in this installment.
Antithrombotic Therapy in Patients with Atrial Fibrillation and Chronic Kidney Disease
The presence of chronic kidney disease (CKD) in patients with atrial fibrillation increases the risk of stroke and thromboembolism (TE) as well as the risk of bleeding, thus complicating their treatment. In this context, it has been suggested that CKD should be included in the CHA2DS2-VASc (Congestive heart failure; Hypertension; Age ≥75 years; Diabetes mellitus; previous Stroke, transient ischemic attack, or thromboembolism; Vascular disease; Age 65 to 74 years; Sex category) score.
Illuminating Clinical Conundrums
After a brutal winter, particularly for those in the Midwest and on the East Coast, spring is finally in the air. I hope everyone had a nice spring break with their families and is eager to read some insightful material on cardiology.

Most Popular

$vacMongoViewPlus$ $vAR$